Articles

SGLT2 inhibitors are not created equal; patient-specific characteristics need to be considered for best efficacy.

Choosing whole fruits instead of juice could help reduce the risk of type 2 diabetes.

Is weight loss always as beneficial as we think?

Liraglutide initiation after hospital discharge was comparable to insulin for glycemic control, with less incidence of hypoglycemia. 

How do the long-term benefits and complicating factors of bariatric surgery in type 1 diabetes patients compare to those with type 2?

Is there an ideal approach to screen and diagnose children and adolescents for prediabetes and diabetes?

While it does not yet have FDA approval, researchers find novel dual SGLT-1/2 inhibitor, sotagliflozin, is efficacious and safe for patients with type 2 diabetes.

A low-calorie diet was a safe and effective treatment for individuals with newly diagnosed T2D and obesity.

Tirzepatide's dual-action may significantly impact a person's weight management and blood glucose compared to GLP-1 receptor agonists like semaglutide.

Recent trials are showing that gastrointestinal surgery may be the new cure for type 2 diabetes, but few patients have access to it.